AZD2115 Single Ascending Dose Study

Clinical trial NCT01283984 · COMPLETED

Trial details

NCT number: NCT01283984
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease Lung Disease Causing Persistent Narrowing of the Airways

Start date: 2011-01-01
Primary completion: 2011-08-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.